As for gastric cancer, Yuan et al. claimed that WNT6, a secreted glycoprotein, promoted multi-drug resistance of gastric cancer [19], and Cho et al. indicated that VEGF-C secretion contributed to chemoresistance of gastric cancer to cisplatin [20]. This evidence concerns the gene WNT6 and gastric cancer.